Medicine
Management of Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD) (formerly Non-Alcoholic Fatty Liver Disease, NAFLD)
The provincially approved Provincial Clinical Guideline on the Management of Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD) is being rolled out to primary care providers and their teams who provide care for patients with MASLD to allow them to adequately manage the majority of these patients in their practice, and to improve appropriate access to specialist care for the subset of MASLD patients that require it.
This clinical guideline is going to take effect immediately.
Please ensure all staff and physicians in your Primary Care Clinic are aware of and familiar with this new provincial clinical guideline.